Chemokine Receptors and Exercise to Tackle the Inadequacy of T Cell Homing to the Tumor Site
While cancer immune therapy has revolutionized the treatment of metastatic disease across a wide range of cancer diagnoses, a major limiting factor remains with regard to relying on adequate homing of anti-tumor effector cells to the tumor site both prior to and after therapy. Adoptive cell transfer...
Main Authors: | Manja Idorn, Per thor Straten |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-08-01
|
Series: | Cells |
Subjects: | |
Online Access: | http://www.mdpi.com/2073-4409/7/8/108 |
Similar Items
-
Chemokine receptor engineering of T cells with CXCR2 improves homing towards subcutaneous human melanomas in xenograft mouse model
by: Manja Idorn, et al.
Published: (2018-08-01) -
Neoantigen-Specific Adoptive Cell Therapies for Cancer: Making T-Cell Products More Personal
by: Valentina Bianchi, et al.
Published: (2020-06-01) -
Modeling ex vivo tumor-infiltrating lymphocyte expansion from established solid malignancies
by: Hannah M Knochelmann, et al.
Published: (2021-01-01) -
Synthetic TILs: Engineered Tumor-Infiltrating Lymphocytes With Improved Therapeutic Potential
by: Anaïs Jiménez-Reinoso, et al.
Published: (2021-02-01) -
Cell Therapy With TILs: Training and Taming T Cells to Fight Cancer
by: Amrendra Kumar, et al.
Published: (2021-06-01)